Protective effects of recombinantBrucella abortusOmp28 against infection with a virulent strain ofBrucella abortus544 in mice
Open Access
- 1 January 2012
- journal article
- Published by The Korean Society of Veterinary Science in Journal of Veterinary Science
- Vol. 13 (3) , 287-292
Abstract
The outer membrane proteins (OMPs) of Brucella (B.) abortus have been extensively studied, but their immunogenicity and protective ability against B. abortus infection are still unclear. In the present study, B. abortus Omp28, a group 3 antigen, was amplified by PCR and cloned into a maltose fusion protein expression system. Recombinant Omp28 (rOmp28) was expressed in Escherichia coli and was then purified. Immunogenicity of rOmp28 was confirmed by Western blot analysis with Brucella-positive mouse serum. Furthermore, humoral- or cell-mediated immune responses measured by the production of IgG1 or IgG2a in rOmp28-immunized mice and the ability of rOmp28 immunization to protect against B. abortus infection were evaluated in a mouse model. In the immunogenicity analysis, the mean titers of IgG1 and IgG2a produced by rOmp28-immunized mice were 20-fold higher than those of PBS-treated mice throughout the entire experimental period. Furthermore, spleen proliferation and bacterial burden in the spleen of rOmp28-immunized mice were approximately 1.5-fold lower than those of PBS-treated mice when challenged with virulent B. abortus. These findings suggest that rOmp28 from B. abortus is a good candidate for manufacturing an effective subunit vaccine against B. abortus infection in animals.Keywords
This publication has 27 references indexed in Scilit:
- Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4 + and CD8 + T Cells as Well as Systemic and Oral Protection against Brucella abortus InfectionInfection and Immunity, 2009
- Role of the Omp25/Omp31 Family in Outer Membrane Properties and Virulence ofBrucella ovisInfection and Immunity, 2007
- BrucellaLumazine Synthase Elicits a Mixed Th1-Th2 Immune Response and Reduces Infection in Mice Challenged withBrucella abortus544 Independently of the Adjuvant Formulation UsedInfection and Immunity, 2003
- Enzyme-Linked Immunosorbent Assay To Differentiate the Antibody Responses of Animals Infected with Brucella Species from Those of Animals Infected with Yersinia enterocolitica O9Clinical and Vaccine Immunology, 2003
- Molecular Host-Pathogen Interaction in Brucellosis: Current Understanding and Future Approaches to Vaccine Development for Mice and HumansClinical Microbiology Reviews, 2003
- Major outer membrane proteins of Brucella spp.: past, present and futureVeterinary Microbiology, 2002
- Protection of BALB/c Mice againstBrucella abortus544 Challenge by Vaccination with Bacterioferritin or P39 Recombinant Proteins with CpG Oligodeoxynucleotides as AdjuvantInfection and Immunity, 2001
- Characterization of Specific Immune Responses of Mice Inoculated with Recombinant Vaccinia Virus Expressing an 18-Kilodalton Outer Membrane Protein ofBrucella abortusClinical and Diagnostic Laboratory Immunology, 2000
- Protection conferred on mice by monoclonal antibodies directed against outer-membrane-protein antigens of BrucellaJournal of Medical Microbiology, 1991
- Entry and Intracellular Localization of Brucella spp. in Vero Cells: Fluorescence and Electron MicroscopyVeterinary Pathology, 1990